Condition: Wilson Disease · Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Patients with Wilson disease have poorer dental and periodontal health and a have lower oral quality of life than control patients. Patients with a neurological form would also more frequently present limitations in the function of the masticatory apparatus. Systemic treatments for Wilson disease are associated with lesions of the oral mucosa. Analysis of copper level in saliva could testify to the effectiveness of copper depletion in treated patients The main objective is to compare the state of dental health between: patients with Wilson disease in the hepatic form and patients with the neurological form, and a population of controls.
This description comes directly from the study's public registry record.
Amélie YAVCHITZ · 01 48 03 64 54 · ayavhitz@for.paris
Aurélia POUJOIS · 01 48 30 66 56 · apoujois@for.paris
Always discuss trial participation with your own doctor first.
| Hopital Charles Foix | Ivry-sur-Seine, France | Active Not Recruiting |
| Hôpital Charles Foix | Ivry-sur-Seine, France | Active Not Recruiting |
| Fondation Adolphe de Rothschild | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05444127